FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management


C 1
Volume 2


Tab 1 - Tercica Press Release (May 2, 2005) Published Material

Tab 2 - Tercica Press Release (June 16, 2004) Published Material

Tab 3 - C. Azcona, et al., Growth Response to rhIGF-I 80 micrograms/kg Twice Daily in Children with Growth Hormone Insensitivity Syndrome: Relationship to Severity of Clinical Phenotype, Clin. Endocrinol. 51: 787-92 (1999) Published Material

Tab 4 - M.B. Ranke, et al., Insulin-Like Growth Factor I Improves Height in Growth Hormone Insensitivity: Two Years’ Results, Hormone Res. 44: 253-64 (1995) Published Material

Tab 5 - J. Guevara-Aguirre, et al., A Randomized, Double Blind, Placebo-Controlled Trial on Safety and Efficacy of Recombinant Human Insulin-Like Growth Factor-Z in Children with Growth Hormone Receptor Deficiency, J. Clin. Endocrinol. Metab. 80: 1393-98 (1995) Published Material

Tab 6 - S.D. Boulware, et al., Comparison of the Metabolic Effects of Recombinant Human Insulin-like Growth Factor-Z and Insulin: Dose-Response Relationships in Healthy Young and Middle-aged Adults, J. Clin. Invest. 93(3): 1131-9 (1994) Published Material

Tab 7 - H.P. Guler, et al., Short-Term Metabolic Effects of Recombinant Human Insulin-Like Growth Factor I in Healthy Adults, N Engl. J. Med. 317(3): 137-40 (1987) Published Material

Tab 8 - S.M. Firth, et al., Impaired Blockade of Insulin-Like Growth Factor I (IGF-I)-Induced Hypoglycemia by IGF Binding Protein-3 Analog with Reduced Ternary Complex-Forming Ability, Endocrinology 143(5): 1669-76 (2002) Published Material

Tab 9 - P.F. Backeljauw, et al., Therapy for 6.5-7.5 Years with Recombinant Insulin-Like Growth Factor I in Children with Growth Hormone Insensitivity Syndrome: A Clinical Research Center Study, J. Clin. Endocrinol. Metab. 86(4): 1504-1510 (2001) Published Material

Tab 10 - P.F. Backeljauw, et al., Prolonged Treatment with Recombinant Insulin-Like Growth Factor-I in Children with Growth Hormone Insensitivity Syndrome - A Clinical Research Center Study, J. Clin. Endocrinol. Metab. 81(9): 3312-7 (1996) Published Material

Tab 11 - S. Malozowski, et al., Growth hormone, insulin-like growth factor I, and benign intracranial hypertension [letter], N. Engl. J. Med. 329(9): 665-666, 666 (Aug. 6, 1993) Published Material

Tab 12 - S. Malozowski and B. Sadel, Risks and benefits of insulin-like growth factor [letter], Ann. Int. Med. 121(7): 549-550, 549 (Oct. 1, 1994) Published Material

Tab 13 - Tercica Press Release (June 6, 2005) Published Material

Tab 14 - H.M. Domene, et al., Deficiency of the Circulating Insulin-like Growth Factor System Associated with Inactivation of the Acid-labile Subunit Gene, N. Engl. J. Med. 350(6): 570-7 (2004) Published Material

Tab 15 - M.J. Abuzzahab, et al., IGF-I Receptor Mutations Resulting in Intrauterine and Postnatal Growth Retardation, N. Engl. J. Med. 349(23): 2211-22 (2003) Published Material

Tab 16 - E.M. Kofoed, et al., Growth hormone insensitivity associated with a STAT5b mutation, N. Engl. J. Med. 349(12): 1139-47 (2003) Published Material

Tab 17 - A.D. Goddard, et al., Mutations of the Growth Hormone Receptor in Children with Idiopathic Short Stature: The Growth Hormone Insensitivity Study Group, N. Engl. J. Med. 333(17): 1093-8 (1995) Published Material

Tab 18 - R.G. Rosenfeld, Insulin-like Growth Factors and the Basis of Growth, N. Engl. J. Med. 349(23): 2184-6 (2003) Published Material

Tab 19 - R.G. Rosenfeld and V. Hwa, Toward a Molecular Basis for Idiopathic Short Stature, J. Clin. Endocrinol. Metab. 89(3): 1066-7 (2004) Published Material

Tab 20 - Z. Laron, The Essential Role of IGF-I: Lessons from the Long-term Study and Treatment of Children and Adults with Laron Syndrome, J. Clin. Endocrinol. Metab. 84(12): 4397-404 (1999) Published Material

Top | Back

Page last updated August 31, 2005 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management